Literature DB >> 18697774

Cancer outlier detection based on likelihood ratio test.

Jianhua Hu1.   

Abstract

MOTIVATION: Microarray experiments can be used to help study the role of chromosomal translocation in cancer development through cancer outlier detection. The aim is to identify genes that are up- or down-regulated in a subset of cancer samples in comparison to normal samples.
RESULTS: We propose a likelihood-based approach which targets detecting the change of point in mean expression intensity in the group of cancer samples. A desirable property of the proposed approach is the availability of theoretical significance-level results. Simulation studies showed that the performance of the proposed approach is appealing in terms of both detection power and false discovery rate. And the real data example also favored the likelihood-based approach in terms of the biological relevance of the results. AVAILABILITY: R code to implement the proposed method in the statistical package R is available at: http://odin.mdacc.tmc.edu/~jhhu/cod-analysis/.

Entities:  

Mesh:

Year:  2008        PMID: 18697774      PMCID: PMC2732272          DOI: 10.1093/bioinformatics/btn372

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  20 in total

1.  Cancer outlier differential gene expression detection.

Authors:  Baolin Wu
Journal:  Biostatistics       Date:  2006-10-04       Impact factor: 5.899

2.  Ratio-based decisions and the quantitative analysis of cDNA microarray images.

Authors:  Y Chen; E R Dougherty; M L Bittner
Journal:  J Biomed Opt       Date:  1997-10       Impact factor: 3.170

3.  COPA--cancer outlier profile analysis.

Authors:  James W MacDonald; Debashis Ghosh
Journal:  Bioinformatics       Date:  2006-08-07       Impact factor: 6.937

4.  Gene expression profiling of primary breast carcinomas using arrays of candidate genes.

Authors:  F Bertucci; R Houlgatte; A Benziane; S Granjeaud; J Adélaïde; R Tagett; B Loriod; J Jacquemier; P Viens; B Jordan; D Birnbaum; C Nguyen
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

5.  Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.

Authors:  S Tozlu; I Girault; S Vacher; J Vendrell; C Andrieu; F Spyratos; P Cohen; R Lidereau; I Bieche
Journal:  Endocr Relat Cancer       Date:  2006-12       Impact factor: 5.678

6.  Role of polymorphic human cytochrome P450 enzymes in estrone oxidation.

Authors:  Alastair E Cribb; M Joy Knight; Dagny Dryer; Judy Guernsey; Kimberly Hender; Marvin Tesch; Tarek M Saleh
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-03       Impact factor: 4.254

7.  Amine oxidase activities in rat breast cancer induced experimentally with 7,12-dimethylbenz(alpha)anthracene.

Authors:  J M Lizcano; E Escrich; T Ribalta; J Muntané; M Unzeta
Journal:  Biochem Pharmacol       Date:  1991-07-05       Impact factor: 5.858

8.  Expression patterns of the ATM gene in mammary tissues and their associations with breast cancer survival.

Authors:  Chuanzhong Ye; Qiuyin Cai; Qi Dai; Xiao-ou Shu; Aesun Shin; Yu-Tang Gao; Wei Zheng
Journal:  Cancer       Date:  2007-05-01       Impact factor: 6.860

9.  Genetics and cytogenetics of multiple myeloma: a workshop report.

Authors:  Rafael Fonseca; Bart Barlogie; Regis Bataille; Christian Bastard; P Leif Bergsagel; Marta Chesi; Faith E Davies; Johannes Drach; Philip R Greipp; Ilan R Kirsch; W Michael Kuehl; Jesus M Hernandez; Stephane Minvielle; Linda M Pilarski; John D Shaughnessy; A Keith Stewart; Herve Avet-Loiseau
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

10.  The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor C delta locus on human chromosome 14q11 and a transcribed region of chromosome 11p15.

Authors:  T Boehm; R Baer; I Lavenir; A Forster; J J Waters; E Nacheva; T H Rabbitts
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  7 in total

1.  Outlier-Based Differential Expression Analysis in Proteomics Studies.

Authors:  Huy Vuong; Kerby Shedden; Yashu Liu; David M Lubman
Journal:  J Proteomics Bioinform       Date:  2011-06-18

2.  Integrative gene set analysis of multi-platform data with sample heterogeneity.

Authors:  Jun Hu; Jung-Ying Tzeng
Journal:  Bioinformatics       Date:  2014-01-30       Impact factor: 6.937

3.  Non-parametric change-point method for differential gene expression detection.

Authors:  Yao Wang; Chunguo Wu; Zhaohua Ji; Binghong Wang; Yanchun Liang
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

4.  Weighted change-point method for detecting differential gene expression in breast cancer microarray data.

Authors:  Yao Wang; Guang Sun; Zhaohua Ji; Chong Xing; Yanchun Liang
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

5.  Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer.

Authors:  Kai Wang; Siu Tsan Yuen; Jiangchun Xu; Siu Po Lee; Helen H N Yan; Stephanie T Shi; Hoi Cheong Siu; Shibing Deng; Kent Man Chu; Simon Law; Kok Hoe Chan; Annie S Y Chan; Wai Yin Tsui; Siu Lun Ho; Anthony K W Chan; Jonathan L K Man; Valentina Foglizzo; Man Kin Ng; April S Chan; Yick Pang Ching; Grace H W Cheng; Tao Xie; Julio Fernandez; Vivian S W Li; Hans Clevers; Paul A Rejto; Mao Mao; Suet Yi Leung
Journal:  Nat Genet       Date:  2014-05-11       Impact factor: 38.330

6.  Comparison of methods to identify aberrant expression patterns in individual patients: augmenting our toolkit for precision medicine.

Authors:  Daniel Bottomly; Peter A Ryabinin; Jeffrey W Tyner; Bill H Chang; Marc M Loriaux; Brian J Druker; Shannon K McWeeney; Beth Wilmot
Journal:  Genome Med       Date:  2013-11-29       Impact factor: 11.117

7.  Pathway-based outlier method reveals heterogeneous genomic structure of autism in blood transcriptome.

Authors:  Malcolm G Campbell; Isaac S Kohane; Sek Won Kong
Journal:  BMC Med Genomics       Date:  2013-09-24       Impact factor: 3.063

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.